- NCIt
- C5028
Loading cancer entity…
Loading cancer entity…
Clinical trials
110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00520598 | Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) | completed | Phase 2 | 511 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 26, 2015 | clinicaltrials |
| NCT00092521 | Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) | completed | Phase 3 | 5,759 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 25, 2015 | clinicaltrials |
| NCT00551187 |
| A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) |
| completed |
| Phase 2 |
| 620 |
| Merck Sharp & Dohme LLCINDUSTRY |
| 0 |
| Jun 8, 2015 |
| clinicaltrials |
| NCT00501137 | A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine(BCGov-01) | completed | Phase 3 | 830 | Simon DobsonOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT00092495 | Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016) | completed | Phase 3 | 3,055 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jan 13, 2015 | clinicaltrials |
| NCT00862810 | Alternate Dosing Schedules Study for HPV Vaccine(ADS) | completed | Phase 4 | 72 | Duke UniversityOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT02280642 | Alternate Dosing Schedules Study for HPV Vaccine (ADS)(ADS) | completed | — | 331 | Duke UniversityOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT01676792 | SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma | completed | Early Phase 1 | 29 | National Cheng-Kung University HospitalOTHER | 1 | Apr 22, 2014 | clinicaltrials |
| NCT01555112 | Safety and Efficacy Study to Test Topical AS101 for External Genital Warts | completed | Phase 1 / Phase 2 | 12 | BioMAS LtdINDUSTRY | 1 | Aug 15, 2013 | clinicaltrials |
| NCT01553994 | Effectiveness Study of Gardasil on Condyloma | completed | — | 500,000 | Lisen Arnheim DahlstromOTHER | 1 | Mar 18, 2013 | clinicaltrials |
| NCT01192282 | Typing of Human Papilloma Virus (HPV) From Female Genital Warts | completed | — | 156 | University of Cape TownOTHER | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00847340 | Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population(GWprofamilia) | completed | — | 342 | La Fundacion para la Investigacion y el DesarrolloOTHER | 0 | Mar 20, 2012 | clinicaltrials |
| NCT00735462 | Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts | completed | Phase 3 | 511 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Jul 20, 2011 | clinicaltrials |
| NCT00674739 | Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts | completed | Phase 3 | 470 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | May 24, 2011 | clinicaltrials |
| NCT01082302 | Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage | completed | Phase 4 | 43 | MediGeneINDUSTRY | 1 | Sep 8, 2010 | clinicaltrials |
| NCT01084824 | A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin | completed | N/A | 70 | North Idaho DermatologyOTHER | 1 | Mar 11, 2010 | clinicaltrials |
| NCT00999986 | Low Dose Cyclophosphamide Treats Genital Warts | completed | Phase 3 | 104 | Huazhong University of Science and TechnologyOTHER | 1 | Nov 25, 2009 | clinicaltrials |
| NCT00499967 | Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts | completed | Phase 1 | 202 | Gilead SciencesINDUSTRY | 1 | Apr 9, 2009 | clinicaltrials |
| NCT00328991 | Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts | completed | N/A | 90 | Minneapolis Veterans Affairs Medical CenterFED | 1 | May 24, 2006 | clinicaltrials |
| NCT00002327 | The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients | completed | Phase 1 | 40 | Gilead SciencesINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Nov 26, 2015source: clinicaltrials